Daniel Lynch Spring Works Therapeutics, Inc. (SWTX) insider trading activity
Daniel Lynch is Director of SpringWorks Therapeutics, Inc.. Currently has a direct ownership of 305,944 shares of SWTX, which is worth approximately $12.7 Million. The most recent transaction as insider was on May 16, 2024, when has been sold 4,095 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
306K
0%
3M change
1.36%
12M change
Total Value Held
$12.7 Million
DANIEL LYNCH Transaction History
Also insider at
DL
Daniel Lynch
Director
Stamford,, CT